Ribosomal protein L7 pseudogene 53 (RPL7P53)

RPL7P53, or ribosomal protein L7 pseudogene 53, is a processed pseudogene in the human genome[2][3][10]. It is non-coding (does not produce a functional protein).\n\nThis pseudogene originated from the RPL7 gene, which encodes 60S ribosomal protein L7, a protein component of the large subunit of the ribosome[1][4]. Like most pseudogenes originating from ribosomal proteins, RPL7P53 does not retain protein-coding function and generally does not contribute to normal cellular protein synthesis or known cellular processes[2][3].\n\nRPL7P53 is not implicated as a therapeutic target, disease biomarker, or functional gene, and is not involved in drug action or known disease processes[2][3][10]. Its presence is typical of the dispersed ribosomal protein pseudogenes throughout the genome, representing evolutionary remnants of gene duplication and retrotransposition events[2][7][10].\nNo evidence exists for its involvement in biological pathways, disease processes, or drug targeting.\n\nKey context:\n- Ribosomal protein L7 (RPL7) is an essential ribosomal protein, but RPL7P53 is a non-functional pseudogene derived from RPL7[3][4][10].\n- Pseudogenes can rarely have regulatory roles, but there is currently no evidence or annotation supporting any regulatory or functional impact of RPL7P53[2][3][10].\n- The majority of ribosomal protein pseudogenes are not translated and are considered “genomic fossils”[7][10].\n\nTherefore:\n- RPL7P53 is not a therapeutic target, receptor, enzyme, or functional gene.\n- No disease, drug, or mechanistic link is established.\n- No safety or biomarker relevance.

Other names

RPL7_30_1785RPL7P53